Search results for "TC"

showing 10 items of 9993 documents

Relationship Between Glucocerebrosidase Activity and Clinical Response to Enzyme Replacement Therapy in Patients With Gaucher Disease Type I

2018

The quantification of enzyme activity in the patient treated with enzyme replacement therapy (ERT) has been suggested as a tool for dosage individualization, so we conducted a study to evaluate the relationship between glucocerebrosidase activity and clinical response in patients with Gaucher disease type I (GD1) to ERT. The study included patients diagnosed with GD1, who were being treated with ERT, and healthy individuals. Markers based on glucocerebrosidase activity measurement in patients' leucocytes were studied: enzyme activity at 15 min. post-infusion (Act75 ) reflects the amount of enzyme that is distributed in the body post-ERT infusion, and accumulated glucocerebrosidase activity …

AdultMalecongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyDiseaseToxicologySeverity of Illness IndexGastroenterology03 medical and health sciencesGlucocerebrosidase activity0302 clinical medicineStatistical significanceInternal medicineLeukocytesHumansMedicineEnzyme Replacement TherapyIn patientProspective Studies030212 general & internal medicineInverse correlationAgedEnzyme AssaysPharmacologyGaucher DiseaseDose-Response Relationship Drugbiologybusiness.industryArea under the curvenutritional and metabolic diseasesGeneral MedicineEnzyme replacement therapyMiddle AgedEnzyme assayTreatment Outcome030220 oncology & carcinogenesisbiology.proteinGlucosylceramidaseFemalebusinessBiomarkersFollow-Up StudiesBasic & Clinical Pharmacology & Toxicology
researchProduct

Outcome of type III Gaucher disease on enzyme replacement therapy: review of 55 cases.

2007

The European Task Force for Neuronopathic Gaucher Disease (NGD) met in 2006 to review its 2001 guidelines. Fifty-five patients from five European countries were reviewed; 29 were male and 26 female. The majority of the patients were homozygous for the L444P mutation. All had been on enzyme replacement therapy (ERT). However, there was considerable variation in the dose of ERT, as well as an uneven distribution of risk factors. Thus, the oldest patients were on the lowest doses, and several had had a total splenectomy, while the youngest patients had a high proportion of compound heterozygosity and were on the highest doses, and very few had had a splenectomy. This heterogeneity rendered ana…

AdultMalecongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyPediatricsHeterozygoteTime FactorsAdolescentmedicine.medical_treatmentSplenectomyEnzyme TherapyDiseaseCompound heterozygosityCentral nervous system diseaseOlder patientsRisk FactorsGeneticsmedicineTotal splenectomyHumansChildGenetics (clinical)Intelligence TestsChemotherapyGaucher Diseasebusiness.industryHomozygotenutritional and metabolic diseasesEnzyme replacement therapymedicine.diseaseSurgeryTreatment OutcomeChild PreschoolGlucosylceramidaseFemaleNervous System DiseasesbusinessJournal of inherited metabolic disease
researchProduct

Outcome of enzyme replacement therapy in patients with Gaucher disease type I. The Romanian experience

2007

This study reports the first evaluation of therapeutic response in Romanian patients with Gaucher disease type I, after therapy with Cerezyme recently became available in our country.24 patients (11-50 years) received Cerezyme 20-60 U/kg every two weeks for at least 18 months. Haemoglobin, platelet count, volume of the liver and spleen, plasma chitotriosidase and the severity score were assessed every 6 months; skeletal radiography and osteodensitometry were also monitored.Eleven patients were splenectomized before start of therapy. Eight patients had anaemia (mean haemoglobin 9.4 g/dl) and 14 patients, of whom 13 were without splenectomy, had thrombocytopenia (mean 65,692/mm3). Haemoglobin…

AdultMalecongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyPediatricsTime FactorsAdolescentBone diseasemedicine.medical_treatmentDiseaseWeight GainSeverity of Illness IndexHemoglobinsGeneticsmedicineHumansIn patientChildGenetics (clinical)ChemotherapyGaucher DiseasePlatelet CountRomaniabusiness.industryLiver DiseasesRomaniannutritional and metabolic diseasesAnemiaEnzyme replacement therapyMiddle Agedmedicine.diseaseCombined Modality TherapyThrombocytopeniaRecombinant Proteinslanguage.human_languageSurgeryHexosaminidasesTreatment OutcomeSplenomegalyQuality of LifeSplenectomylanguageGlucosylceramidaseFemaleBone DiseasesbusinessFollow-Up StudiesJournal of Inherited Metabolic Disease
researchProduct

A Prospective Randomized Study of Corticosteroids as Adjuvant Drugs to Opioids in Advanced Cancer Patients

2007

This randomized controlled study evaluated the role of corticosteroids as adjuvants to opioid therapy in 76 advanced cancer patients with pain who requiring strong opioids. Patients were divided in 2 groups. Group O received conventional opioid treatment. Group OS received dexamethasone (8 mg orally) along with conventional treatment. Pain and symptom intensity, sense of well-being, and opioid escalation index and distress score were recorded at weekly intervals until death. No differences in pain intensity, opioid consumption, and opioid escalation index were found in 66 patients who survived 33 to 37 days. Corticosteroids did not provide significant additional analgesia to opioids, but p…

AdultMalecorticosteroidmedicine.medical_treatmentAnti-Inflammatory Agentslaw.invention03 medical and health sciences0302 clinical medicinePharmacotherapyRandomized controlled trial030502 gerontologylawNeoplasmsmedicineHumansProspective Studiesopioids in advanced cancer patientsprospective randomized studyProspective cohort studyDexamethasoneAgedPain MeasurementAged 80 and overAnalysis of VarianceChemotherapyadjuvant drugDose-Response Relationship Drugbusiness.industryPalliative CareGeneral MedicineMiddle AgedPain IntractableAnalgesics OpioidTreatment OutcomeOpioidChemotherapy Adjuvant030220 oncology & carcinogenesisAnesthesiaDrug Therapy CombinationFemale0305 other medical scienceCancer painbusinessAdjuvantFollow-Up Studiesmedicine.drugAmerican Journal of Hospice and Palliative Medicine®
researchProduct

Is Active Transport and Leisure-Time Physical Activity Associated With Inflammatory Markers in US Adults? A Cross-Sectional Analyses From NHANES.

2019

BACKGROUND: To investigate the association between levels of active transport and leisure-time physical activity (LTPA) with C-reactive protein, white blood cell count, body mass index, waist circumference, and lipids in a large representative sample of adults residing in the United States. METHODS: Cross-sectional data from the National Health and Nutrition Examination Survey. Adjusted multinomial logistic regressions were carried out to quantify associations between levels of self-reported active transport (or LTPA) and quintiles of anthropometric measures and serum markers. RESULTS: A total of 3248 adults were included. For serum inflammatory biomarkers, the authors observed a lower like…

AdultMalecyclingWaistNational Health and Nutrition Examination SurveyLeisure timePhysical activityBiological Transport ActiveEXERCISE030204 cardiovascular system & hematologyMotor ActivityLogistic regressionHealth outcomeswalking03 medical and health sciencesYoung AdultFATNESS0302 clinical medicineLeisure ActivitiesACTIVITY ENERGY-EXPENDITUREEnvironmental healthMedicineHumansCORONARY-HEART-DISEASEOrthopedics and Sports MedicineanthropometricExercisePublic Environmental & Occupational HealthMETABOLIC SYNDROMERISKScience & Technologybusiness.industryMORTALITY030229 sport sciencesAnthropometryMiddle AgedNutrition SurveysC-REACTIVE PROTEINUnited Stateswalking cycling anthropometricCross-Sectional StudiesCARDIOVASCULAR-DISEASEFemaleFOLLOW-UPbusinessLife Sciences & BiomedicineBody mass indexJournal of physical activityhealth
researchProduct

A prospective, randomized, controlled trial comparing three different gonadotropin regimens in oocyte donors: ovarian response, in vitro fertilizatio…

2009

Objective To compare the efficacy of three different gonadotropin regimens in an oocyte donation program. The analysis of cost minimization also was evaluated. Design Prospective, randomized, controlled study. Setting Instituto Universitario–IVI, Valencia, Spain. Patient(s) One thousand twenty-eight donors undergoing a GnRH agonist protocol were assigned randomly to one of three groups: group 1 (n = 346), only recombinant FSH (rFSH); group 2 (n = 333), only highly purified menotropin (HP-hMG); and group 3 (n = 349), rFSH plus HP-hMG. One thousand seventy-nine oocyte recipients. Intervention(s) Controlled ovarian stimulation. Main Outcome Measure(s) Controlled ovarian stimulation parameters,…

AdultMaleendocrine systemmedicine.medical_specialtyAdolescentPregnancy Ratemedicine.drug_classmedicine.medical_treatmentFertilization in Vitrolaw.inventionYoung AdultFollicle-stimulating hormoneOvulation InductionRandomized controlled trialCost SavingsPregnancylawmedicineHumansGynecologyIn vitro fertilisationOocyte Donationbusiness.industryOvaryObstetrics and GynecologyFertility Agents FemaleMiddle AgedPregnancy rateTreatment OutcomeReproductive MedicineFemaleOvulation inductionMenotropinGonadotropinbusinessInfertility FemaleGonadotropinsEmbryo qualityFertility and Sterility
researchProduct

Thyroid Stimulating Antibodies Are Highly Prevalent in Hashimoto's Thyroiditis and Associated Orbitopathy

2016

Thyroid-associated orbitopathy (TAO) rarely occurs in patients with Hashimoto's thyroiditis (HT).There is evidence that TSH receptor stimulating antibodies (TSAb) play a role in the pathogenesis of TAO. In this report, the prevalence of TSAb in HT patients with and without TAO was studied.This is a longitudinal observational study.The study took place in an academic joint thyroid-eye clinic.A total of 1055 subjects were included.TSAb was measured with a Food and Drug Administration-cleared bioassay that uses Chinese hamster ovary cells expressing a chimeric TSH receptor and a cAMP response element-dependent luciferase. Results of TSAb activity were reported as percentage of specimen-to-refe…

AdultMaleendocrine systemmedicine.medical_specialtyAdolescentendocrine system diseasesEndocrinology Diabetes and MetabolismClinical Biochemistry030209 endocrinology & metabolismContext (language use)CHO CellsHashimoto DiseaseBiochemistryThyroiditisPathogenesisYoung Adult03 medical and health sciencesCricetulus0302 clinical medicineEndocrinologyCricetinaeInternal medicineAnimalsHumansMedicineYoung adultReceptorbiologybusiness.industryBiochemistry (medical)ThyroidOutcome measuresReceptors ThyrotropinMiddle Agedmedicine.diseaseeye diseasesGraves OphthalmopathyEndocrinologymedicine.anatomical_structure030220 oncology & carcinogenesisbiology.proteinFemaleAntibodybusinessImmunoglobulins Thyroid-StimulatingThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Effect of the GLP-1 analog liraglutide on satiation and gastric sensorimotor function during nutrient-drink ingestion

2012

Background/Aim:Liraglutide, a glucagon-like peptide-1 analog, induces weight loss. We investigated whether liraglutide affects gastric accommodation and satiation by measuring the intragastric pressure (IGP) during nutrient-drink consumption and using the barostat technique.Methods:Ten healthy volunteers (HVs) were tested after placebo, 0.3, 0.6 or 1.2 mg liraglutide administration. IGP was studied during intragastric nutrient-drink (1.5 kcal ml(-1)) infusion (60 ml min(-1)), while the HVs scored their satiation on a graded scale until maximal satiation. In a separate session, isobaric distentions were performed using the barostat with stepwise increments of 2 mm Hg starting from minimal di…

AdultMaleendocrine systemmedicine.medical_specialtyManometryEndocrinology Diabetes and MetabolismTreatment outcomeMedicine (miscellaneous)SatiationSettore BIO/09 - FisiologiaBody Mass IndexBeveragesEatingDouble-Blind MethodGlucagon-Like Peptide 1Internal medicinegastric accomodation GLP-1 satiationPressuremedicineHumansIngestionNutrition and DieteticsDose-Response Relationship DrugLiraglutidebusiness.industryStomachdigestive oral and skin physiologyNauseaLiraglutidePostprandial PeriodTreatment OutcomeEndocrinologyGastric EmptyingFemaleGastrointestinal Motilitybusinessmedicine.drugInternational Journal of Obesity
researchProduct

Prevalence, Phenotype, and Psychosocial Well-Being in Euthyroid/Hypothyroid Thyroid-Associated Orbitopathy.

2015

At the onset of thyroid-associated orbitopathy (TAO), most patients are hyperthyroid, while scarce data are available on euthyroid/hypothyroid TAO. The aim of this study was to assess the prevalence, phenotype, and psychosocial burden of patients with initially euthyroid/hypothyroid TAO.The medical records of 461 consecutive and unselected patients with TAO followed at a specialized joint thyroid-eye clinic were analyzed within this retrospective cross-sectional study. Main outcome measures were the prevalence of initially eu- or hypothyroid TAO as well as ophthalmic signs and symptoms, disease-specific quality of life (QoL), work impairment, and rate of psychotherapy in initially eu-/hypot…

AdultMaleendocrine systemmedicine.medical_specialtyPediatricsendocrine system diseasesAdolescentCross-sectional studyEndocrinology Diabetes and MetabolismThyroid GlandThyroiditisGraves' ophthalmopathyYoung AdultEndocrinologyQuality of lifeHypothyroidismInternal medicinemedicineOrbital DiseasesPrevalenceHumansEuthyroidAgedRetrospective StudiesAged 80 and overbusiness.industryThyroidRetrospective cohort studyMiddle Agedmedicine.diseaseThyroid DiseasesGraves OphthalmopathyPsychotherapymedicine.anatomical_structureEndocrinologyCross-Sectional StudiesPhenotypeTreatment OutcomeMultivariate AnalysisQuality of LifeRegression AnalysisFemalebusinessPsychosocialhormones hormone substitutes and hormone antagonistsThyroid : official journal of the American Thyroid Association
researchProduct

Clinical success of intrauterine insemination cycles is affected by the sperm preparation time.

2013

Objective To determine the impact of the time interval from the end of sperm preparation (TSP) to intrauterine insemination (IUI) on the outcome. Design Prospective multicentre cohort study. Setting Seven French centers (assisted reproduction group in northeastern France, four academic centers, and three clinics). Patient(s) Eight hundred sixty-two IUI cycles (709 patients) managed by gonadotropins were studied. Intervention(s) Cycles were stimulated by either FSH or hMG, and hCG was administrated when the leading follicle diameter measured >15 mm. IUIs were performed ∼36 hours after ovulation triggering. Main Outcome Measure(s) Generalized linear mixed models for binary outcomes were used …

AdultMaleendocrine systemmedicine.medical_specialtyTime FactorsPregnancy Ratemedia_common.quotation_subjectReproductive medicinelaw.inventionSpecimen HandlingSemen qualityRandomized controlled trialOvulation InductionlawPregnancyOdds RatioMedicineHumansProspective StudiesOvulationmedia_commonUnexplained infertilityInsemination Artificial HomologousGynecologyPregnancybusiness.industryAge FactorsObstetrics and GynecologyFertility Agents Femalemedicine.diseaseSpermatozoaTissue DonorsSemen AnalysisPregnancy rateFertilityTreatment OutcomeReproductive MedicineInfertilityMultivariate AnalysisLinear ModelsFemaleFrancebusinessCohort studyFertility and sterility
researchProduct